Recombinant Human Protein Kinase Inhibitor Beta (PKIb), Unconjugated, E. coli

Produktübersicht

• Artikelname: Recombinant Human Protein Kinase Inhibitor Beta (PKIb), Unconjugated, E. coli
• Artikelnummer: BIM-RPU52984
• Hersteller Artikelnummer: RPU52984
• Alternativnummer: BIM-RPU52984-50UG,BIM-RPU52984-100UG,BIM-RPU52984-1MG
• Hersteller: Biomatik Corporation
• Wirt: E. coli
• Kategorie: Proteine/Peptide
• Applikation: Control, SDS-PAGE, WB
• Spezies Reaktivität: Human
• Konjugation: Unconjugated
• Alternative Synonym: PKI-B, PRKACN2, CAMP-Dependent Protein Kinase Inhibitor Beta

Produktbeschreibung

Recombinant Human Protein Kinase Inhibitor Beta (PKIb) is a purified Prokaryotic Protein. Purity: >95% by SDS-PAGE. Host: E. coli. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens). Target Name: Protein Kinase Inhibitor Beta (PKIb). Target Synonyms: PKI-B, PRKACN2, CAMP-Dependent Protein Kinase Inhibitor Beta. Accession Number: Q9C010. Gene ID: 5570. Expression Region: Met8~Glu76. Tag Info: N-terminal His Tag. Theoretical MW: 15kDa. Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose. Storage: -20C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.

Produkteigenschaften

• Molekulargewicht: 15kDa
• Tag: N-Terminal His Tag
• NCBI: 5570
• Puffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
• Expression System: Prokaryotic Expression
• Reinheit: >95% by SDS-PAGE
• Formulierung: Freeze-dried powder
• Target-Kategorie: Protein Kinase Inhibitor Beta (PKIb)